Avadel Pharmaceuticals Shares Outstanding 2006-2020 | AVDL

Avadel Pharmaceuticals shares outstanding from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Avadel Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2019 37
2018 37
2017 42
2016 41
2015 44
2014 36
2013 25
2012 25
2011 25
2010 24
2009 24
2008 24
2007 24
2006 24
2005 23
Avadel Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2020-09-30 58
2020-06-30 70
2020-03-31 41
2019-12-31 37
2019-09-30 37
2019-06-30 37
2019-03-31 37
2018-12-31 37
2018-09-30 37
2018-06-30 37
2018-03-31 39
2017-12-31 42
2017-09-30 41
2017-06-30 42
2017-03-31 43
2016-12-31 41
2016-09-30 41
2016-06-30 41
2016-03-31 41
2015-12-31 43
2015-09-30 41
2015-06-30 40
2015-03-31 43
2014-12-31 39
2014-09-30 39
2014-06-30 38
2014-03-31 28
2013-12-31 26
2013-09-30 25
2013-06-30 25
2013-03-31 25
2012-12-31 25
2012-09-30 25
2012-06-30 25
2012-03-31 25
2011-12-31 25
2011-09-30 25
2011-06-30 25
2011-03-31 25
2010-12-31 25
2010-09-30 24
2010-06-30 24
2010-03-31 24
2009-12-31 24
2009-09-30 24
2009-06-30 24
2009-03-31 24
2008-12-31 24
2008-09-30 24
2008-06-30 24
2008-03-31 24
2007-12-31 24
2007-09-30 24
2007-06-30 24
2007-03-31 24
2006-12-31 24
2006-09-30 24
2006-06-30 24
2006-03-31 24
2005-12-31 23
2005-09-30 24
2005-06-30 22
2005-03-31 23
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.426B $0.059B
Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.133B 41.50
Takeda Pharmaceutical (TAK) Japan $55.867B 10.42
Astellas Pharma (ALPMY) Japan $28.839B 18.01
Eisai (ESALY) Japan $21.946B 19.12
UCB SA (UCBJF) Belgium $21.755B 0.00
Merck (MKGAF) Germany $19.813B 25.98
Catalent (CTLT) United States $15.589B 46.63
Grifols, S.A (GRFS) Spain $12.520B 14.34
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.500B 23.81
Neurocrine Biosciences (NBIX) United States $8.887B 69.94
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.561B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.902B 12.77
IPSEN SA ADR (IPSEY) France $7.862B 0.00
Ionis Pharmaceuticals (IONS) United States $7.025B 68.82
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.272B 21.76
United Therapeutics (UTHR) United States $6.003B 12.78
Arrowhead Pharmaceuticals (ARWR) United States $5.859B 0.00
Evotec AG (EVTCY) Germany $4.893B 332.50
PTC Therapeutics (PTCT) United States $4.335B 0.00
Sage Therapeutics (SAGE) United States $4.304B 0.00
Hypermarcas (HYPMY) Brazil $3.756B 13.81
ChemoCentryx (CCXI) United States $3.737B 0.00
FibroGen (FGEN) United States $3.642B 0.00
Nektar Therapeutics (NKTR) United States $2.956B 0.00
Cronos Group (CRON) Canada $2.839B 0.00
Revolution Medicines (RVMD) United States $2.776B 0.00
Pacira BioSciences (PCRX) United States $2.753B 59.77
Corcept Therapeutics (CORT) United States $2.652B 25.65
Taro Pharmaceutical Industries (TARO) Israel $2.623B 13.39
Xencor (XNCR) United States $2.354B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.862B 15.93
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.768B 0.00
Trillium Therapeutics (TRIL) Canada $1.711B 0.00
Heron Therapeutics (HRTX) United States $1.613B 0.00
USANA Health Sciences (USNA) United States $1.594B 14.03
Translate Bio (TBIO) United States $1.355B 0.00
Indivior (INVVY) United States $1.235B 15.31
Endo (ENDP) Ireland $1.221B 1.85
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.193B 8.29
Ocular Therapeutix (OCUL) United States $1.179B 0.00
Zogenix (ZGNX) United States $1.174B 0.00
Karyopharm Therapeutics (KPTI) United States $1.086B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.081B 0.00
Tilray (TLRY) Canada $0.997B 0.00
ImmunoGen (IMGN) United States $0.994B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.862B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.840B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.783B 0.00
Esperion Therapeutics (ESPR) United States $0.752B 0.00
Radius Health (RDUS) United States $0.751B 0.00
VAXART, INC (VXRT) United States $0.701B 0.00
Collegium Pharmaceutical (COLL) United States $0.666B 39.33
Spectrum Pharmaceuticals (SPPI) United States $0.665B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.650B 33.88
Aerie Pharmaceuticals (AERI) United States $0.596B 0.00
Chinook Therapeutics (KDNY) United States $0.577B 0.00
Organogenesis Holdings (ORGO) United States $0.552B 0.00
Siga Technologies (SIGA) United States $0.547B 15.37
Ardelyx (ARDX) United States $0.545B 0.00
Flexion Therapeutics (FLXN) United States $0.535B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.495B 0.00
Akebia Therapeutics (AKBA) United States $0.477B 0.00
Molecular Templates (MTEM) United States $0.442B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.430B 0.00
Innate Pharma SA (IPHYF) France $0.407B 0.00
TherapeuticsMD (TXMD) United States $0.397B 0.00
DURECT (DRRX) United States $0.378B 0.00
Harpoon Therapeutics (HARP) United States $0.370B 0.00
Profound Medical (PROF) Canada $0.366B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.362B 9.43
Calithera Biosciences (CALA) United States $0.341B 0.00
Concert Pharmaceuticals (CNCE) United States $0.338B 0.00
Altimmune (ALT) United States $0.334B 0.00
KalVista Pharmaceuticals (KALV) United States $0.333B 0.00
Rafael Holdings (RFL) United States $0.327B 0.00
MEI Pharma (MEIP) United States $0.326B 0.00
Redhill Biopharma (RDHL) Israel $0.320B 0.00
CASI Pharmaceuticals (CASI) United States $0.320B 0.00
Summit Therapeutics (SMMT) United States $0.288B 0.00
Menlo Therapeutics (VYNE) United States $0.277B 0.00
CTI BioPharma (CTIC) United States $0.276B 0.00
Jounce Therapeutics (JNCE) United States $0.267B 0.00
Lannett Co Inc (LCI) United States $0.261B 6.90
Nature's Sunshine Products (NATR) United States $0.244B 15.71
IMV INC (IMV) Canada $0.231B 0.00
Aquestive Therapeutics (AQST) United States $0.227B 0.00
Xeris Pharmaceuticals (XERS) United States $0.224B 0.00
OptiNose (OPTN) United States $0.222B 0.00
Alpine Immune Sciences (ALPN) United States $0.216B 0.00
Otonomy (OTIC) United States $0.207B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.194B 0.00
Heat Biologics (HTBX) United States $0.176B 0.00
Taiwan Liposome (TLC) Taiwan $0.161B 0.00
Champions Oncology (CSBR) United States $0.145B 0.00
Aclaris Therapeutics (ACRS) United States $0.142B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.139B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.129B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.126B 0.00
Infinity Pharmaceuticals (INFI) United States $0.116B 0.00
Lipocine (LPCN) United States $0.107B 0.00
MediWound (MDWD) Israel $0.101B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.101B 0.00
ProPhase Labs (PRPH) United States $0.099B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.080B 0.00
KemPharm (KMPH) United States $0.080B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.079B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.079B 0.00
Biomerica (BMRA) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.075B 0.00
ElectroCore (ECOR) United States $0.068B 0.00
Novan (NOVN) United States $0.067B 0.00
Nutriband (NTRB) United States $0.066B 0.00
Natural Alternatives (NAII) United States $0.065B 125.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.064B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.063B 0.00
Addex Therapeutics (ADXN) Switzerland $0.061B 0.00
GTx (ONCT) United States $0.057B 0.00
Recro Pharma (REPH) United States $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.051B 0.00
Onconova Therapeutics (ONTX) United States $0.049B 0.00
Forward Pharma (FWP) Denmark $0.047B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.044B 22.39
Adamis Pharmaceuticals (ADMP) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.039B 5.68
Opiant Pharmaceuticals (OPNT) United States $0.035B 0.00
Vical (BBI) United States $0.035B 0.00
Iterum Therapeutics (ITRM) Ireland $0.034B 0.00
Sundial Growers (SNDL) Canada $0.030B 0.00
Neos Therapeutics (NEOS) United States $0.029B 0.00
PolarityTE (PTE) United States $0.025B 0.00
Regulus Therapeutics (RGLS) United States $0.024B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.020B 0.00
Jaguar Animal Health (JAGX) United States $0.017B 0.00
Cyanotech (CYAN) United States $0.016B 27.00
Eyegate Pharmaceuticals (EYEG) United States $0.016B 0.00
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.016B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.014B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
Shineco (TYHT) China $0.010B 0.00
JanOne (JAN) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00